Could a simple symptom check replace a grueling exercise test for kids?
NCT ID NCT07766460
First seen Aug 14, 2026 ยท Last updated Aug 14, 2026
Summary
This study looks at children aged 5 to 18 who had an exercise challenge test to see if certain symptoms, like wheezing or coughing during exercise, can predict a positive result. The goal is to find simpler ways to diagnose exercise-induced bronchoconstriction, a condition where physical activity triggers narrowing of the airways. By identifying these predictive factors, doctors may be able to better decide which children need the test.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors identify which children need an exercise challenge test, making diagnosis of exercise-induced breathing problems faster and more accessible.
- What could go wrong
- This is an observational study, so it cannot prove cause and effect. The findings may not apply to all children, and the predictive factors may not be accurate enough to replace the exercise test.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA (DIAGNOSIS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHRU de Nancy
Nancy, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can ancient cupping ease asthma?
- Could common food additives be friend or foe? a massive study investigates
- Can a new injection help tame asthma? a trial seeks answers
- Could a Two-Day steroid course replace five days for severe asthma in kids?
- Could a simple breathing pattern ease asthma symptoms and improve sleep?
- Oral asthma drug KT-621 tested for Long-Term safety